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SUMMARY 
lt has previously been shown that covalent incorporation of the 
photoreactive adenosine derivative (R)-2-azido-N 11-p-hydroxy-
phenytisopropyladenosine [(R)-AHPIA] into the A, adenosine re-
ceptor of intact fat cells Ieads to a persistent activation of this 
receptor, resulting in a reduction of celular cAMP Ieveis [Mol. 
Pharmacol. 30:403-409 (1986)]. ln contrast, covalent incorpo-
ration of (R)-AHPIA into human platelet membranes, which con-
tain only stimulatory A2 adenosine receptors, reduces adenytate 
cyclase Stimulation via these receptors. This effect of (R)-AHPIA 
is speciflc for the A2 receptor and can be prevented by the 
adenosine receptor antagonist theophylline. Binding studies in-
Adenosine is a modulator of many physiological functions, 
including the nervous and cardiovascular systems, metabolism, 
and immune responses. Most of its effects appear to be me-
diated via membrane-bound receptors (for a review, see Refs. 
1-3). On the basis of biochemical and pharmacological experi-
ments, these receptors have been subdivided into the At (or R;) 
and the A2 (or R.) subtypes (4, 5). According to the classical 
concept, the A1 receptor mediates an inhibition and the A2 
receptor a stimulation of adenylate cyclase. Pharmacologically, 
the A2 receptor is characterized by a high affinity for 5 I-
substituted adenosine analogues, such 88 NECA, and the At 
receptor by a high affinity for N 8-substituted adenosine ana-
logues, such 88 (R)-PIA. 
We have recently used an agonist photoaffinity Iabel, (R)-
AHPIA (6), for the investigation of the activation mechanism 
of the At adenosine receptor (7). Covalent labeling of the 
receptor of intact fat cells resulted in its persistent activation, 
88 judged from a persistent reduction of cAMP Ievels. These 
data were interpreted 88 providing evidence for the validity of 
the occupancy theory of receptor activation. The occupancy 
theory of receptor activation (8) predicts that a receptor is 
activated 88 long 88 it is occupied by an agonist, whereas the 
rate theory (9) assumes that receptor activation is proportional 
to the rate of receptor occupation. 
dicate that up to 90% of A2 receptors can be blocked by 
photoincorporation of (R)-AHPIA. However, the remaining 10-
20% of A2 receptors are sufficient to mediate an adenylate 
cyclase Stimulation of up to SOOk of the control value. Similarty, 
the activation via these 10-20% of receptors occurs with a haJf-
life that is only 2 times Ionger than that in control membranes. 
This indicates the presence of a receptor reserve, with respect 
to both the extent and the rate of adenytate cyclase Stimulation. 
These observations require a modification of the models of 
receptor-adenytate cyclase coupling, which is described in the 
accompanying paper [Mol. Pharmacol. 39:524-530 (1991)]. 
Although (R)-AHPIA is about 60-fold A1 selective, it is also 
an agonist at the A2 receptor (6). Therefore, it might also be 
used as a tool to investigate the activation mechanism of the 
A2 receptor. In the present study we report that, in contrast to 
the persistent activation of A1 receptors, covalent labeling of 
the A2 receptor with (R)-AHPIA results in a persistent block-
ade. This irreversible blockade can be used to investigate the 
coupling mechanism between the A2 receptor and adenylate 
cyclase. To this end, we have applied the classical analyses of 
concentration-response curves following receptor inactivation 
that have led to the concepts of spare receptors or receptor 
reserve (10) and to models of receptor-effector coupling (11, 
12). 
Experimental Procedures 
Materials 
(R)-AHPIA was syntbesized as described earlier (13). (32P]Ortbo-
phoapbate and (3H)NECA were obtained from Amersham-Buchler 
(Braunschweig, West Germany) and New England Nuclear (Dreieich, 
West Germany), respectively. Sepharoae CL68 and POlO columna 
were purcba.aed from Pharmacia (Freiburg, West Germany). All otber 
materials were from sources described previously (14). 
AIIIREVIATIONS: NECA, 51 -N-ethytcarboxamidoadenoslne; (R)-PIA, (R)-N.-phenylisopropyladen: (R)-AHPIA, (R)-2-azido-N•-p-hydroxyphen-
ylllopropyladenne; Gpp(NH)p. guanosine 5 I -(ß. -y-imido)triphosphate: XAC, xanthine ami1e cougeua; CHAPS, 3-((:H:holamidopro-
pyl)dmethylammonio)-1-propanesulfonate. 
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Methods 
Membraae preparationa. Outdated platelet-rich plasma (5-6 days 
after preparation) was obtained from a local blood bank, and mem-
branes were prepared as described earlier (6). In several instances, 
ezperimenta were also done with membranes from fresh platelets; the 
results were essentially the same, although adenylate cyclase activity 
was aomewhat higher in membranes from fresh platelets. Membrane& 
from isolated rat epididymal fat cells were prepared as described (7). 
The protein content was determined according to the method of Peter-
aon (15). 
Adenylate cyclue aaay. The activity of adenylate cyclase of 
human platelet and rat fat cell membranes was determined as described 
earlier (6). To detect receptor-mediated stimulation, GTP was present 
at 1 "M, whereas 10 "M GTP and 10 "M forskolin were used tobest 
detect receptor-mediated inhibition (6). Unless stated otherwise, the 
incubation temperature was 37•. [ a-32P)ATP was synthesized according 
to the method of Walsethand Johnaon (16). 
In some experiments, GTP (1 "M) was replaced by Gpp(NH)p (1 
~M) to cause quasiirreversible activation of the enzyme (17). These 
ezperimenta were done at 25 • to slow down the rate of activation. 
Pbo&oalftnjty labeliDg. Platelet membranes were incubated with 
different concentrations of (R)-AHPIA in 50 mM Tris· HCl, pH 7.4, 10 
mM MgCI2 (TM buffer), at ao·. The same concentrations of the 
nonphotolabile parent compound (R)-PIA were used for controls. After 
5 min, the samples were put on ice and irradiated for 3 min with UV 
light, uaing a Mineralight TM 15 lamp at a distance of 15 cm. The 
membranes were then diluted 10-fold with the same buffer and centri-
fupd at 39,000 x 8 for 5 min. This washing step was repeated twice, 
and the final pellet was resuspended in 50 mM Tris·HCl, pH 7.4, 
containing 1 mM MgCI2. 
In some experiments, 8-azidoadenosine was used as the photolabile 
compound. The treatment of samples was exactly as described for (R )-
AHPIA. 
Rat fat cell membranes were labeled by the same procedure. In order 
to stabilize the adenylate cyclase activity (18) and to promote di880Cia-
tion of (R)-AHPIA that was noncovalently bound to A1 receptors (6), 
a different washing buffer was used, 50 mM Tris·HCI, pH 7.4, 10 "M 
forskolin, 100 "M GTP. The fmal pellet was resuspended in 50 mM 
Tris·HCl, pH 7.4, containing forakolin and GTP, to give fmal concen-
trations of 10 "M of both compounds in the adenylate cyclase assay. 
Solubilized Az receptors, eluted as the peak of specific [3H]NECA 
binding from the Sepharose column (see below), were incubated with 
10 "M (R)-AHPIA [or (R)-PIA for controls] for 60 min at o· and then 
UV irradiated, as described above. Separation of noncovalently bound 
(R)-AHPIA from the solubilized receptor was achieved by three dialysis 
steps against 50 volumes of elution buffer, followed by "desalting" over 
PD 10 columns. 
Solubilization and gel rlltration of As adenoeine recepton. Az 
adenosine receptors of human platelet membranes were solubilized as 
recently described ( 19). In brief, platelet membranes were centrifuged 
at 13,000 x 8 for 5 min, and the pellet was resuspended at a protein 
concentration of 10 mgjml in TM buffer containing 1% CHAPS. After 
30 min on ice, the aolution was diluted with 4 volumes of TM buffer 
and then centrifuged at 100,000 x 8 for 30 min. The supematant was 
dialyzed at 4 • against four successive portions of TM buffer containing 
0.02% CHAPS. In order to separate the A2 receptors from non-receptor 
binding sites for (3H)NECA (19), the supematant was subsequently 
loaded onto a 60- x 1.6-cm Sepharose CL6B column, which was eluted 
witb the dialysis buffer at 4 •. Fractions of 2 ml were collected and 
tested for binding activity. 
Binding aaay. The binding of [3H]NECA to the fractions was 
measured in a total volume of 300 "1, containing 10 nM radioligand and 
200-~1 aliquots of the eluate fractions. (R)-PIA (100 ~M) was used to 
define nonspecific binding (19). The incubation Iasted for 60 min at 
o• and was terminated by filtration through Whatman GF /B glass fiber 
filters that bad been presoaked in 0.3% polyethyleneimine, as described 
for solubilized A1 receptors (20). 
Data analyais. Concentration-response curves were fitted as de-
scribed earlier (7), with the general equation: 
[L]" 
E = Eo + E". ECso" + [L]" (I) 
with E being effect, Eo being basal effect, E", being maximal effects of 
the individual curve, n being the slope factor, EC110 being the EC110 
value, and L being the Iigand concentration. For the experiment shown 
in Fig. 4, the data were fitted to a model of pharmacological agonism 
(21): 
T"[L]" 
E = E"_ (Ko +[LW+ T"[L)" (II) 
with E"_ being the absolute maximal effect, and Ko being the di880Cia-
tion constant of the ligand-receptor interaction; the "transducer ratio" 
T denotes the ratio of total receptor concentration, Rr, to KB, the 
concentration of receptor-ligand complexes eliciting a half-maximal 
effect (0.5 X E".): T = Rr/Ks. T1 and Tz denote the transducer ratios 
without and with receptor blockade, respectively. 
This algorithm is based upon a two-step model of agonist-effect 
coupling (21), which includes (a) agonist-receptor interaction, govemed 
by a di880Ciation constant Ko, and (b) a similar receptor-effect rela-
tionship, with the corresponding constant K8 • Because both Rr and KB 
determine tbe efficiency of the receptor-effect relationship, these two 
terms are combined to give the transducer ratio T. 
The accumulation of cAMP in kinetic adenylate cyclase experiments 
was fitted to the integrated rate equation: 
[cAMP]= AV~t- ~ (1- e-Ar..t)) + V" x t (111) 
where V" denotes the basal enzyme activity, AV.., the activity increase 
induced by NECA at equilibrium, and kon the observed rate constant 
of activation. In addition, the measured values were numerically differ-
entiated with a three-point formula, in order to plot A V as a function 
oftime. 
The parameters of these equations were estimated from the data by 
nonweighted nonlinear curve fitting. 
Results 
Wehave previously shown that covalent labeling of A1 aden-
osine receptors of intact fat cells causes a persistent reduction 
of intracellular cAMP Ievels (7). Similar results can be obtained 
with fat cell membranes (Fig. 1); covalent labeling with 100 nM 
(R)-AHPIA, followed by extensive washing, reduced the activ-
ity by more than 30%, compared with controls. The effect of 
covalently bound (R)-AHPIA corresponded to about 80% of 
the maximal inhibition obtained with reversibly bound (R)-
PIA. The maximal inhibition of adenylate cyclase activity via 
A1 receptors [10 ~tM (R)-PIA] was not affected by the pretreat-
ment with (R)-AHPIA. This suggests that the receptors that 
were not covalently labeled with (R)-AHPIA remained acces-
sible for activation by (R)-PIA. 
In contrast, pretreatment of platelet membranes with (R)-
AHPIA (up to 100 ~M) did not result in a measurable activation 
of A2 adenosine receptors (Fig. 1). However, pretreatment with 
(R)-AHPIA reduced the stimulatory effect of the A2 receptor 
agonist NECA; using 10 ~tM (R)-AHPIA for the covalent label-
ing, 10 ~M NECA stimulated adenylate cyclase activity by only 
70%, compared with 190% in (R)-PIA-pretreated control mem-
branes. lt appears that covalent labeling of the membranes 
with (R)-AHPIA resulted in an irreversible blockade of A2 
receptors, because (a) this blockade could not be washed out 
with even more extensive washing procedures and (b) the 
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Flg. 1. Effects of covalent incorporation of (R)-AHPIA into membranes 
of rat fat cells (A, receptor) and human platelets (~ receptor) on 
adenylate cyclase activity. Fat cell membranes were pretreated with 100 
nM (R)-AHPIA or (R)-PIA, and platelet membranes wtth 10 ~AM (R)-AHPIA 
or (R)-PIA (accontlug to the approxinately 1 00-fok:t lower affinity of the 
lgands for the A. receptor), as described in Experimental Procedures. 
After removal of noncovalenUy bound IIgand, the adenylate cyclase 
activity was measurad under basal conditions (control) or with maximal 
sti'nulatlon of A, receptors [1 0 1'M (R)-PIA, in the presence of 10 ~AM GTP 
nt 10 ~AM forskoln] or ~ receptor [10 ~AM NECA, in the prasence of 1 
1'M GTP). 
TABLE 1 
Effecta of pretrutment wtth Henoelne derivlltlves on adenylate 
cyclue ectlvlly of .................. memtnnes 
Aft.fJK pralncubation wlth the adanoline dertvatlves, lJV in'adiation, and washing, as 
detaled in Expertmental Procedlns, the adanylate cyclase activity of the pretreated 
membranes was assayed under basal oondltlons and with maximal Stimulation by 
NECA and prosteglandln E,. Data.,. means ± standan:l errors of ttwee independ-
n experments, wlth ~snp~es. 
(R)-PIA (1 0 ~AM) 
(R)-AHPIA (10 ~AM) 
8-Azldoadenosine 
(10 ~AM) 
NECA Prostlg1ll dn E1 
(101&1') (10"u) 
pmd d cNIPJmg d pn1fir X min 
15.5 ± 1.5 45.0 ± 1.5 170 ± 10 
16.0 ± 0.5 27.5 ± 2.5 176 ± 4 
15.0 ± 1.6 42.4 ± 4.4 168 ± 12 
products resulting from UV irradiation of (R)-AHPIA in TM 
buffer retained the agonist activity of (R)-AHPIA, although 
with a somewhat lower EC110 value [5.5 ~o&M veraus 2.3 ~o&M (R)-
AHPIA]. 
The specificity of this effect was confirmed along three lines. 
Firstly, pretreatment with (R)-AHPIA did not affect stimula-
tion of adenylate cyclase by other hormones, such as prosta-
glandin E1 (Table 1). Secondly, pretreatmentofthe membranes 
with 100 ~o&M 8-azidoadenosine, a compound that proved to be 
devoid of A2 receptor activity, did not affect the NECA-stimu-
lated activity. And thirdly, the effect of (R)-AHPIA could be 
prevented by the adenosine receptor antagonist theophylline 
(Fig. 2); increasing concentrations of (R)-AHPIA during the 
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CONCENTRATION OF R-AHPIA (MJ 
Flg. 2. Effects of theophylline on the inaetivatlon of A, receptors by 
covalent incorporatlon of (R)-AHPIA. Human platelet membranes were 
pretreated with different conoentrations of (R)-AHPIA, washed, and 
assayed for adenylate cydase activity in the presence of 10 ~AM NECA, 
as described in the legend to F'tg. 1. Theophyline concentrations dlrtng 
the pretreatment were 0 (e), 3 (II), 10 <•). and 100 "M (t). ICao values 
of (R)-AHPIA pretreatment for the reductlon of stimulated adenylate 
cyclase activity were 1.2, 4.8, 16.8, and >100 "M, respectlvely. 
pretreatment produced a concentration-dependent reduction of 
NECA-stimulated activity, with an IC110 value of 1.2 ~o&M. The-
ophylline shifted this curve in a parallel manner to higher 
concentrations, suggesting a competitive antagonism between 
theophylline and (R)-AHPIA. From the data, an apparent pA2 
value for theophylline of 5.77 can be calculated; however, for 
reasons outlined below, this is an overestimate of the affinity 
of theophylline. 
We have interpreted the persistent activation of A1 receptors 
by covalently bound (R)-AHPIA as evidence for the occupancy 
theory of receptor activation (7, 8). The blockade of A2 receptors 
by covalent labeling with (R)-AHPIA would be compatible with 
the rate theory of receptor activation, as developed by Paton 
(9). However, kinetic experiments on the activation of aden-
ylate cyclase by NECA argue against this (Fig. 3); activation 
by both submaximal (300 nM) and maximal (10 ~M) concentra-
tions of NECA results in an exponential activation time course, 
with a faster apparent activation by the higher concentration 
of NECA. This is compatible only with models based on the 
occupancy theory (22). Consequently, it must be assumed that, 
although the receptor is activated according to the occupancy 
theory, covalent occupancy of the A2 receptor with (R )-AHPIA 
Ieads to inactivation of the receptor. 
The extent of such an irreversible blockade is classically 
estimated by measuring the effects of an agonist with and 
without receptor blockade (10). Fig. 4 shows the stimulation of 
adenylate cyclase activity by NECA after blockade of the A2 
receptors by pretreatment with (R)-AHPIA, as well as that in 
(R)-PIA-pretreated control membranes. Pretreatment with 
(R)-AHPIA markedly reduced the efficacy and the potency of 
NECA; the maximal stimulation decreased from 160% to 90%, 
and the ECso value increased from 280 nM to 900 nM. Simul-
taneaus fitting of the curves to Eq. II estimates a K0 value for 
NECA (under the conditions of the adenylate cyclase assay) of 
2.3 ~o&M and a muimalstimulation (in pretreated membranes) 
of almost 200%. The transducer ratio, T, is 5.8 in (R)-PIA-
pretreated and 0.98 in (R)-AHPIA-pretreated membranes. Be-
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Fig. 3. Kinetics of the Stimulation of adenylate cyclase in human platelet 
membranes by NECA. The assay was Started by the addition of mem-
branes and was conducted for the indicated times at 37°, under basal 
conditions (0) and in the presence of 300 nM (A) or 10 llM (e) NECA. 
The data (pmol of cAMP produced/mg of protein) were fitted by the 
lntegrated exponential Eq. 111. lnset, NECA-stimulated activity, tJ.V, in 
pmol of cAMP/mg of protein x min (numerically differentiated data, fitted 
by a simple exponential curve using the parameters obtained from the 
Integreted curve). The estinated parameters are: maximal Stimulation, 
tJ.V~, by 300 flM NECA and 10 llM NECA, 8.9 and 28.2 pmol of cAMP/ 
mg of protein x min, respectively; and rate constants, k01" 1 .1 (300 nM 
NECA) and 3.1 min-1 (10 ~otM NECA). 
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CONCENTRATION OF NECA IMl 
Fig. 4. ConcentratiorHjependent stimulation of adenylate cyclase by 
NECA, in human platelets after photoincorporation using 1 0 ~otM (R)-
AHPIA (e) and in control membranes pretreated with 1 0 llM (R)-PIA (0). 
After the pretreatment, the adenylate cyclase (AC) activity was measured 
at 37° in the presence of different concentrations of NECA. The GTP 
concentration was 1 "M. The concentration-response curves were fitted 
with Eq. II, giving the foflowing parameter estimates: maximal Stimulation, 
E,_, 200%, affinity of NECA, Ko. 2.3"M; slope factor, n, 0.8; transducer 
ratios, r, (control membranes), 5.8, and r 2 [(R)-AHPIA-pretreated mem-
branes], 1.8. 
cause T is proportional to the number of receptors ( T = Rr/ 
KE), this indicates that the proportion of covalently blocked 
receptors is ( Tt- T2)/T1 = 83%. This is a surprisingly high yield, 
compared with photoincorporation of (R)-AHPIA into A1 re-
ceptors of about 40% (6). 
Therefore, we attempted to measure the blockade of A2 
receptors with radioligand binding techniques. Due to their 
high nonspecific binding, neither [3H]NECA (90% nonspecific 
binding) (23) nor [3H)XAC (80-90% nonspecific binding) (24) 
gave conclusive results in binding assays with platelet mem-
branes. In order to overcome the high nonspecific binding, we 
have recently described the separation of non-receptor [3H] 
NECA binding sites from A2 adenosine receptors by gel filtra-
tion (19). This technique allows binding assays with [3H]NECA 
to the solubilized A2 receptor, which elutes with the void 
volume. Fig. 5 shows the elution profile of (R)-AHPIA- and 
(R )-PIA-pretreated and subsequently solubilized membranes, 
as determined by [3H)NECA binding. A peak of specific [3H] 
NECA binding, defined by the presence of 100 ~tM (R)-PIA, 
eluted with the void volume of solubilized control membranes, 
followed by a larger peak of nonspecific [3H]NECA binding. 
Pretreatment with (R)-AHPIA d.rastically reduced the amount 
of specific [3H]NECA binding; the total specific binding 
(shaded areas in Fig. 5) was reduced by 80%. This value is 
similar to the estimate of irreversibly blocked A2 receptors from 
adenylate cyclase experiments (Fig. 4). Thus, it must be con-
cluded that covalent labeling of A2 receptors with (R)-AHPIA 
results in a blockade of a large proportion (80-85%) of recep-
tors. 
FR ACTION 
Fig. 5. Gel filtration of solubilized platelet membranes after pretreatment 
with (R)-PIA (top) and (R)-AHPIA (bottom). After photoincorporation of 
(R)-AHPIA (1 0 ~otM) or control treatment with (R)-PIA (1 0 ~otM), membranes 
were solubilized with 1% CHAPS, and the extract was applied to a 
Sepharose CL6B column. The eluted fractions were tested for ['H]NECA 
binding. 0, Total binding; ~. nonspecific binding [plus 100 ~otM (R)-PIA]. 
Specific binding (shaded areas) was 219 ± 15 fmol/mg of protein after 
(R)-PIA pretreatment and 43 ± 7 fmol/rng of protein after (R)-AHPIA 
pretreatment (means ± Standard errors of three independent experi-
ments). 
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Similar results were obtained when A2 receptors were first 
aolubilized and subjected to gel filtration and the pooled peak 
containing the receptors was then incubated with (R)-AHPIA 
(10 ~o&M, o-, 30 min) and UV irradiated. After removal of 
noncovalently bound Iigand by dialysis and desalting, the (R)-
PIA- and the vehicle- (1% dimethyl sulfoxide in TM buffer) 
pretreated membranes bound 31 and 37 fmol of (3H)NECA/mg 
of protein, respectively. The (R)-AHPIA-pretreated samples 
bound only 2 fmol/mg of protein. This corresponds to a pho-
toincorporation of (R)-AHPIA of more than 90%. 
Irreversible blockade of receptors has been used as a tool for 
the investigation of receptor-effector coupling by many authors. 
In particular, this method enables a differentiation between 
catalytic and noncatalytic activation of adenylate cyclase by 
receptors (12). Such an investigation is facilitated if the acti-
vation of the enzyme by the receptor is essentially irreversible. 
An activation that appears to be permanent within the time 
scale of the present experiments can be obtained by substituting 
for GTP in the adenylate cyclase assays with the hydrolysis-
resistant analogue Gpp(NH)p (17) and by lowering the incu-
bation temperature from 37• to 25•; Fig. 6 shows that, in the 
presence ofGTP, the addition ofthe adenosine receptor antag-
onist XAC (10 ~o&M) causes reversion of the NECA stimulation. 
In the presence of Gpp(NH)p, the adenylate cyclase remains 
in the NECA-stimulated state after addition of XAC. 
These conditions were used to determine the characteristics 
of adenylate cyclase stimulation by NECA in (R)-AHPIA-
pretreated veraus (R)-PIA-pretreated membranes (Fig. 7). In 
(R)-PIA-pretreated control membranes, 10 #'M NECA stimu-
lated adenylate cyclase with an apparent rate constant k = 0.19 
min-1, to a maximal extent A V eq = 5.3 pmol of cAMP /mg of 
protein x min. In (R)-AHPIA-pretreatedmembranes, the stim-
ulation occurred more slowly (k = 0.11 min-1) and to a smaller 
extent (A V eq = 2. 7 pmol of cAMP /mg of protein X min). Thus, 
the receptors remaining after blockade with (R)-AHPIA are 
not capable of activating all adenylate cyclase molecules. In 
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Flg. I. Irreversible Stimulation by NECA of human platelet adenylate 
cyclase in the presence of Gpp(NH)p (eire/es) and reversible Stimulation 
in the presence of GTP (Squares). Basal and NECA (1 0 lolM)-stimulated 
adenytate cyctase actlvity were each assayed at 25°, in the presence of 
eHher 1 lolM Gpp(NH)p or 1 ~ GTP. Shown ls the NECA-stimu&ated 
actMty inaease, av (as in the inset of F'tg. 3). After 15 min, A2 raoeptors 
were blocked by addition of 100 ~ XAC (arrow) (open symbols). Butter 
containing the solvent (1% dimethyl sulfoxide) was added at the same 
tine to control samples (f/1/ed symbols). 
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Flg. 7. Kinetics of the irreversible Stimulation of adenylate cyclase by 10 
lolM NECA in human platelets after photoinoorporation using 10 ~&M (R)-
AHPIA (filled symbols) andin control membranes pretreated with 10 lolM 
(R)-PIA (open symbols). After the pretreatment, the adenylate cyclase 
activity was l1l88Sll"8d at 25°. using 1 ,.., Gpp(NH)p lnier basal condi-
tions (trlangles) or in the presenoe of 10 lolM NECA (e/rcles). The data 
(pmol of cAMP produced/mg of protein) were fitted by the integrated 
exponential Eq.lll. /nset, NECA-stimulated activity, av, as in Fig. 3 (pmol 
of cAMP/mg of protein X mil). Ct.wve fttting gives the following par8meter 
estinates: maximal stimulation, av ... after control and (R)-AHPIA pre-
treatment, 5.3 and 2.7 pmol of cAMP/mg of protein x min, respectively; 
and rate constants, k011 , 0.19 min-1 {control) and 0.11 min-1 [{R)-AHPIA 
pretreatment]. 
addition, the reduction of the receptor number by about 80% 
reduces the rate of adenylate cyclase activation by only 40%. 
Thus, the reduction of the receptor number resulted in a 
proportional reduction of neither A V eq nor kon, i.e., both param-
eters are not linearly related to receptor number. 
Discussion 
The photolabile adenosine analogue (R)-AHPIA is a full 
agonist at At and a partial agonist at A2 adenosine receptors 
(6). Covalent incorporation of (R)-AHPIA into A1 receptors 
Ieads to a persistent activation of the receptors both in intact 
fat cells (7) and in fat cell membranes (Fig. 1). In contrast, 
covalent labeling of A2 receptors with (R)-AHPIA does not 
activate the receptors but results in a persistent blockade. The 
available data clearly indicate that this blockade can only be 
due to covalent occupation of the binding site by (R)-AHPIA. 
Although the covalent occupation of A2 receptors with the 
agonist (R)-AHPIA Ieads to receptor blockade, kinetic experi-
ments on the activation of adenylate cyclase via A2 receptors 
show that the receptor is not activated according to the rate 
theory (9); the time course of activation can be adequately 
fitted by a monoexponential curve, i.e., it appears to be first 
order. Such first-order kinetics are predicted only by models 
based on the occupancy theory (8, 11, 12, 22, 25). Therefore, 
models based on the validity of the occupancy theory can be 
used to analyze the effects of covalent labeling of A2 receptors 
with (R)-AHPIA. 
First, the activation of adenylate cyclase by NECA after 
blockade with (R)-AHPIA allows an estimate ofthe transducer 
ratio T (21) of A2 receptors in platelet membranes. This ratio 
is 5.8 in control membranes, i.e., there are almost 6 times as 
many A2 receptors as needed forahalf-maximal activation of 
adenylate cyclase. Consequently, the EC50 value of NECA in 
' 
Q) 
c. (/) 
CO 
522 lohu., al. 
stimulating adenylate cyclase is about 10 times lower than its 
Ko value. Because the transducer ratio is not only tissue specific 
but also agonist specific, this difference will be less for partial 
agonists. For example, whereas NECA stimulated the adenylate 
cyclase in control pretreated membranes by 170% (Fig. 4), (R)-
PIA maximally stimulated the enzyme in the same membranes 
by 90% (data not shown). The maximal effect a and the EC50 
value of a given compound can be derived from Eq. II (21): 
a = E".T/(1 + T) 
ECso = Ko/(1 + T) 
for the case of slope factors n = 1. It follows from E". = 200% 
(Fig. 4) and a = 90% that T = 0.8 for (R)-PIA, compared with 
T = 5.8 for NECA. Consequently, the ECso value of adenylate 
cyclase activation overestimates the affinity of NECA for the 
A2 receptor by a factor of 6.8, butthat of (R)-PIA by a factor 
of only 1.8. Together with the demonstration of spare At 
receptors in fat cells (7), this shows that the simple determi-
nation of agonist affinities and selectivities from adenylate 
cyclase data gives data that differ from the true affinities, as 
seen in radioligand binding experiments. 
Second, a number of mechanistic models based on the occu-
pancy theory have been developed for receptor-effector cou-
pling in general and for receptor-adenylate cyclase coupling in 
particular. Of these, only a few can account for the relatively 
simple kinetic and steady state properties of adenylate cyclase 
activation (11, 25). The characteristic features observed in the 
present study are (a) first-order kinetics of adenylate cyclase 
activation by different concentrations of NECA, (b) a nonlinear 
relationship between extent of Stimulation and receptor num-
ber, (c) a nonlinear relationship between the rate of stimulation 
and receptor number, and (d), as a consequence of these non-
linear relationships (which correspond to the classical concept 
of a "receptor reserve"), a difference between the EC50 value of 
NECA and the Ko value of about 10-fold. 
The simple first-order kinetics can be accomodated by two 
general models, described by Levitzki and colleagues (11, 12, 
25) as "precoupled" and "collision-coupling" models. The pre-
coupled model assumes a preexisting receptor-effector complex, 
which upon agonist binding becomes activated. The collision-
coupling model assumes that the agonist-occupied receptor 
catalytically activates many effectors. Although the adenosine 
receptor of turkey erythrocytes has been reported to be precou-
pled to adenylate cyclase (12), the differences between K0 and 
ECso (feature d) clearly dismiss the precoupled model for the 
human platelet A2 receptor. In addition, the precoupled model 
predicts that a reduction of receptor number must result in a 
proportional decrease of irreversibly activated effectors; this 
contrasts with feature b. Although the collision-coupling model 
can accomodate differences between ECso and Kn (26), it would 
predict that reduction of receptor number results in a propor-
tional reduction in activation rate but no alteration of the 
maximal effect if activation is irreversible (11). This is because 
it is assumed that the receptors can catalytically activate all 
adenylate cyclase molecules. In our experiments, reduction of 
the receptor number reduced both the maximal effect and the 
rate of activation (features band c). However, it is likely that 
receptors are capable of activating only a limited number of 
adenylate cyclase molecules, which are in their neighborhood. 
In the accompanying paper, we propose a restricted collision-
coupling model, which combines features of the collision-cou-
pling model proposed by Levitzki and co-workers (11, 25) and 
the random hit matrix model developed by Bergman and Rech-
ter (27). This model appears to account for all the observations 
(a to d) of the present study. 
The reasons why covalent incorporation of (R)-AHPIA ac-
tivates the At and blocks the A2 receptor, although both recep-
tors are activated according the occupancy theory, arenot clear. 
A possible explanation is that the covalent bond is formed at 
the 2-position of (R)-AHPIA. It has been proposed that the 2-
position of adenosine is important for A2 receptor binding, and 
a 2-phenylamino substituent confers some A2 selectivity to 
adenosine (28). The idea that the 2-position interacts with the 
A2 receptor is supported by the high percentage of photoincor-
poration of (R)-AHPIA, via its 2-azido substituent, into A2 
receptor compared with At receptors. The A2 receptor may 
consequently be more sensitive to the formation of a covalent 
bond at this position than the At receptor. 
Although the photoincorporation of (R)-AHPIA into A2 re-
ceptors was very high, we have been unable to obtain a specif-
ically labeled band in sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis of a variety of membranes, using t251-AH-
PIA. Membranes used for this purpose were prepared from 
human platelets, NIE 115 neuroblastoma cells, and rat lung 
and liver. This failure is probably due to the low affinity of 
(R)-AHPIA for A2 receptors, which is in the micromolar range. 
In summary, we have shown that (R)-AHPIA can be very 
effectively photoincorporated into A2 adenosine receptors. The 
resulting blockade of the receptor provides a tool for the study 
of the activation mechanism of the receptor. This reveals the 
presence of spare A2 receptors in human platelet membranes 
and calls for a modification of the classical models of A2 
receptor-adenylate cyclase coupling. Such a model will be pro-
posed in the accompanying paper. 
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